Screener
Integra LifeSciences IART Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $214,415 | $235,048 |
| Short-term investments | 59,669 | 28,693 |
| Trade accounts receivable, net of allowances of $7,326 and $7,230 | 267,188 | 278,849 |
| Inventories, net | 492,005 | 492,735 |
| Prepaid expenses | 104,344 | 96,089 |
| Other current assets | 53,861 | 28,130 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's short-term investments?
- Integra LifeSciences (IART) reported short-term investments of $59.67M in Q2 2026.
- How has Integra LifeSciences's short-term investments changed year-over-year?
- Integra LifeSciences's short-term investments increased by 67.2% year-over-year, from $35.69M to $59.67M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Integra LifeSciences's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude